Scandion Oncology A/S hereby announces that an agreement has been signed with Sedermera Fondkommission in order to finalize plans for an Initial Public Offering (IPO) at Spotlight Stock Market, Stockholm, in the fall of 2018.
Scandion Oncology A/S hereby announces that an agreement has been signed with Sedermera Fondkommission in order to finalize plans for an Initial Public Offering (IPO) at Spotlight Stock Market, Stockholm, in the fall of 2018.